Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia.
Saved in:
| Title: | Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia. |
|---|---|
| Authors: | Salceda-Rivera V; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Ortiz-Lazareno PC; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Hernández-Flores G; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico., Vazquez-Urrutia JR; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Meza-Arroyo J; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Pardo-Zepeda M; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Romo-Rubio H; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Barba-Barba C; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico., Sánchez-Zubieta F; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Departamento de Clinicas de Reproduccion Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Barrón-Gallardo CA; Departamento Académico de Disciplinas Especializantes de Ciencias de la Salud, Universidad Autonoma de Guadalajara, Zapopan, JAL, Mexico., Gonzalez-Ramella O; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico., Bravo-Cuellar A; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, JAL, Mexico. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1401262. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39421449 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salceda-Rivera+V%22">Salceda-Rivera V</searchLink>; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Ortiz-Lazareno+PC%22">Ortiz-Lazareno PC</searchLink>; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Hernández-Flores+G%22">Hernández-Flores G</searchLink>; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Vazquez-Urrutia+JR%22">Vazquez-Urrutia JR</searchLink>; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Meza-Arroyo+J%22">Meza-Arroyo J</searchLink>; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Pardo-Zepeda+M%22">Pardo-Zepeda M</searchLink>; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Romo-Rubio+H%22">Romo-Rubio H</searchLink>; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Barba-Barba+C%22">Barba-Barba C</searchLink>; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Sánchez-Zubieta+F%22">Sánchez-Zubieta F</searchLink>; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Departamento de Clinicas de Reproduccion Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Barrón-Gallardo+CA%22">Barrón-Gallardo CA</searchLink>; Departamento Académico de Disciplinas Especializantes de Ciencias de la Salud, Universidad Autonoma de Guadalajara, Zapopan, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Ramella+O%22">Gonzalez-Ramella O</searchLink>; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Department of Pediatric Hemato-Oncology, Hospital Civil de Guadalajara 'Dr. Juan I. Menchaca', Guadalajara, JAL, Mexico.; Centro Universitario de Ciencias de la Salud, School of Medicine, Universidad de Guadalajara, Guadalajara, JAL, Mexico.<br /><searchLink fieldCode="AU" term="%22Bravo-Cuellar+A%22">Bravo-Cuellar A</searchLink>; Immunology Division, Western Biomedical Research Center, Mexican Social Security Institute, Guadalajara, JAL, Mexico.; Doctoral Program in Biomedical Sciences, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, JAL, Mexico.; Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, JAL, Mexico. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1401262. <i>Date of Electronic Publication: </i>2024 Oct 03 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39421449 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1401262 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1401262 Titles: – TitleFull: Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salceda-Rivera V – PersonEntity: Name: NameFull: Ortiz-Lazareno PC – PersonEntity: Name: NameFull: Hernández-Flores G – PersonEntity: Name: NameFull: Vazquez-Urrutia JR – PersonEntity: Name: NameFull: Meza-Arroyo J – PersonEntity: Name: NameFull: Pardo-Zepeda M – PersonEntity: Name: NameFull: Romo-Rubio H – PersonEntity: Name: NameFull: Barba-Barba C – PersonEntity: Name: NameFull: Sánchez-Zubieta F – PersonEntity: Name: NameFull: Barrón-Gallardo CA – PersonEntity: Name: NameFull: Gonzalez-Ramella O – PersonEntity: Name: NameFull: Bravo-Cuellar A IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 10 Text: 2024 Oct 03 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |